ArticleBMJ open2023

Towards Response ADAptive Radiotherapy for organ preservation for intermediate-risk rectal cancer (preRADAR): protocol of a phase I dose-escalation trial.

Maaike E Verweij et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.